PTEN and endometrioid adenocarcinoma: Loss of PTEN function in the endometrium is considered to be an early event in carcinogenesis and is associated with a favorable prognosis, since PTEN mutation rates are higher in patients with endometrioid adenocarcinoma or precancerous lesions compared with patients with advanced or metastatic endometrial cancer.